Daily Clinical Briefing · Educational reading for healthcare professionals

Concussion, hearing loss and PSMA therapy

March 21, 2026

Concussion reassessment, hearing loss, cognition, and PSMA imaging decisions in metastatic prostate cancer.

PEARL OF THE DAY

reassuring first assessment after head impact does not exclude concussion; safe decisions depend on serial review and follow-up.

Summary

Today's medical podcast selection leans toward brain health but stays clearly multi-specialty, making it useful for clinical learning and revision. The dominant teaching thread is that early reassurance can be unsafe: concussion needs serial review after head impact, and hearing-loss counselling in older adults needs careful wording that frames hearing aids as a possible way to reduce cognitive decline risk rather than a guarantee against dementia.

For medical students, this is practical revision on reassessment, evidence language and how imaging changes treatment decisions. For clinicians, it sharpens day-to-day judgement: take the athlete off for a quieter concussion review, counsel older adults without overstating benefit, and read PSMA PET with CT before offering lutetium so clinically important disease and treatment toxicity are not missed. These medical podcasts teach bedside decision-making across neurology, ageing and oncology without losing practical relevance.

More from today’s podcasts

Brain health and the evolution of the Premier League Head Injury Protocol: The past, present and future. EP#584

Serial assessment matters: a normal first pitch-side check does not rule out concussion. Head injury decisions improve when clinicians use video-supported review, remove athletes for quieter reassessment, and plan follow-up because symptoms can emerge after play.

Treating Hearing Loss

Hearing aid counselling in older adults should stay precise: the reported association is a possible reduction in dementia risk over seven years, not prevention. The revision point is to link hearing impairment management with cognition while avoiding claims that overstate the evidence.

PSMA Lutetium

PSMA lutetium only helps when the scan and the patient match the treatment. Review PSMA PET with CT to avoid missing clinically important disease that is not tracer-avid, and monitor blood count, renal function and dry mouth or eye toxicity before each cycle.

How these briefings are prepared

Daily Clinical Briefings are prepared using ChatGPT Pro from the show notes and educational output for that day’s episodes. Iain Beardsell then checks the briefing for accuracy.

This describes the current briefing process. Item-specific review dates are shown only where documented. The original podcasts remain the sources; MedPod’s briefing is additional educational material.

Read about MedPod’s editorial approach

Report an error or source concern — please include the article title and link, without patient-identifying information.

Continue learning with MedPod Learn

Browse and listen to medical podcasts free in the app.
Premium adds notes, MCQs, reflections and activity tracking, with exportable learning records.
Try the St Emlyn’s sample